A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses
- PMID: 9883918
- DOI: 10.1111/j.1471-0528.1998.tb10005.x
A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses
Abstract
Objective: To determine whether there is a relationship between maternal serum insulin-like growth factor-I and fetal growth, consistent with the hypothesis that insulin-like growth factor-I influences maternal constraint upon fetal growth by controlling placental transfer.
Design: A prospective, observational study.
Setting: Fetal medicine unit and antenatal clinic of a large teaching hospital.
Population: One hundred and forty-one pregnant women identified as having small or normally grown fetuses.
Methods: Fetuses were scanned every two weeks with maternal venesection at each visit. Cases (birthweight < 5th centile) were assigned to two groups: fetal growth restriction due to placental dysfunction (umbilical artery Doppler, growth velocity pulsatility index > +2 SD; n = 25) and normal small-for-gestational-age (normal Doppler, growth velocity and amniotic fluid; n = 27). Eighty-nine controls had birthweights between the 5th and the 95th centiles, normal Doppler, growth velocity and amniotic fluid. Insulin-like growth factor-I was measured by radioimmunoassay, and its relationship to gestational age and birthweight was assessed by regression analysis. Comparisons between case groups were made by Student's t test or analysis of covariance to allow for the effect of birthweight.
Outcome measure: The last insulin-like growth factor-I level before delivery within the different subgroups.
Results: In controls, maternal insulin-like growth factor-I increased with gestational age (r = 0.40; P = 0.0001) but did not correlate with birthweight. Insulin-like growth factor-I was low in the mothers of growth restricted fetuses (-1.56 SD; P = 0.0001), but not in those with small-for-gestational age fetuses.
Conclusions: The control and small-for-gestational-age data suggest that maternal insulin-like growth factor-I is not associated with endocrine control of normal placental function. Low insulin-like growth factor-I relates to poor placental transfer, as indicated by Doppler, rather than to low birthweight. Whether this is a regulatory mechanism, a cause or a consequence of placental dysfunction needs further study.
Comment in
-
A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses.Br J Obstet Gynaecol. 1999 Nov;106(11):1232-3. doi: 10.1111/j.1471-0528.1999.tb08168.x. Br J Obstet Gynaecol. 1999. PMID: 10549982 No abstract available.
Similar articles
-
Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth.Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F113-7. doi: 10.1136/fn.82.2.f113. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10685983 Free PMC article.
-
An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses.Placenta. 1999 May;20(4):325-30. doi: 10.1053/plac.1998.0387. Placenta. 1999. PMID: 10329354
-
Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study.BMC Med. 2017 Aug 31;15(1):164. doi: 10.1186/s12916-017-0928-z. BMC Med. 2017. PMID: 28854913 Free PMC article.
-
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.Am J Obstet Gynecol. 2018 Feb;218(2S):S855-S868. doi: 10.1016/j.ajog.2017.12.004. Am J Obstet Gynecol. 2018. PMID: 29422214 Review.
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
Cited by
-
Management of fetal growth restriction.Arch Dis Child Fetal Neonatal Ed. 2007 Jan;92(1):F62-7. doi: 10.1136/adc.2005.082297. Arch Dis Child Fetal Neonatal Ed. 2007. PMID: 17185432 Free PMC article. Review.
-
Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth.Placenta. 2015 May;36(5):559-66. doi: 10.1016/j.placenta.2015.02.006. Epub 2015 Feb 24. Placenta. 2015. PMID: 25771406 Free PMC article.
-
Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth.Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F113-7. doi: 10.1136/fn.82.2.f113. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10685983 Free PMC article.
-
Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells.Biomolecules. 2021 Sep 18;11(9):1382. doi: 10.3390/biom11091382. Biomolecules. 2021. PMID: 34572595 Free PMC article.
-
Effect of maternal anthropometry and metabolic parameters on fetal growth.Indian J Endocrinol Metab. 2012 Sep;16(5):754-8. doi: 10.4103/2230-8210.100669. Indian J Endocrinol Metab. 2012. PMID: 23087859 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources